The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Lumendi sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Lumendi is a medical equipment company that designs and develops endoscopic surgical devices. The company provides minimally invasive endoscopes and surgical devices. Its product portfolio includes colonic sutures, colonic endoscopic ultrasound devices, colonoscopes, and endoscopic submucosal dissection. Its Endoluminal Interventional Platform (EIP) technology collaborates seamlessly with existing endoscopic equipment to facilitate endoluminal therapeutic procedures, including intricate polypectomies. The company’s major brands are Dilumen EZ1, Dilumen EZ1 Glide, and Dilumen C. Lumendi is headquartered in Maidenhead, Berkshire, the UK.
The key metrics of Lumendi related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Lumendi is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Lumendi.
For a detailed understanding of the performance of Lumendi, buy the report here.